Kamada is a biopharmaceutical company engaged in development, production and marketing of specialty plasma therapeutics, specific and general immune globulins and other prescribed medicines using sophisticated chromatographic purification technology.
Kamada's manufacturing facility holds latest and most advanced equipment for production of high-quality products. The fully computerized facility keeps Kamada at the cutting edge in maintenance of the highest standards of quality and safety for its products.
While operating in a surrounding that has recently become more demanding for higher safety and quality levels, greater product availability and at the same time maintaining competitive price level s , Kamada is being able to provide the necessary solutions for all of the above requirements by delivering virally inactivated, highly pure products sourced out of top-quality, US- FDA approved, plasma sources while retain ing profitability thanks to its efficient production process.
Recent Publications by Kamada ltd: |  |
Signal intensity of motor and sensory cortices on T2-weighted and FLAIR images: intraindividual comparison of 1.5T and 3T MRI.
We compared the signal intensity of motor and sensory cortices on... | 7th April, 2009
| Department of Radiology, University of Occupational and Environmental
| Eur Radiol. 2008 Dec;18(12):2949-55. Epub 2008 Jul 19.
DOI Direct Link |
Two-photon absorption properties of Dehydrobenzo[12]annulenes and hexakis(phenylethynyl)benzenes: effect of edge-linkage.
Two-photon absorption (TPA) properties of two trefoil-shaped compounds... | 9th January, 2008
| Photonics Research Institute, National Institute of Advanced Industrial
| Chemphyschem. 2007 Dec 21;8(18):2671-7.
DOI Direct Link |
[Parents and nursing staff's expectations regarding the nurse's work in a NICU]
The general purpose of this investigation was to identify parent and... | 7th April, 2007
| Departamento de Enfermagem,
| Rev Esc Enferm USP. 2006 Sep;40(3):404-11.
|
Creation of novel cell-penetrating peptides for intracellular drug delivery using systematic phage display technology originated from Tat transduction domain.
Many biologically active proteins need to be delivered intracellularly to... | 6th April, 2007
| Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical
| Biol Pharm Bull. 2007 Feb;30(2):218-23.
|
Shear bond strengths of four resin bonding systems to two silica-based machinable ceramic materials.
The purpose of this study was to evaluate the bond strength between four... | 17th February, 2007
| Division of Fixed Prosthodontics and Oral Rehabilitation, Nagasaki
| Dent Mater J. 2006 Sep;25(3):621-5.
|
→View more Kamada ltd research publications. |
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 252 times since April 2007, the link to the organisation's website has been followed 44 times
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
Kamada ltd
